A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I)
Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a...
Saved in:
Published in | Growth hormone & IGF research Vol. 52; p. 101318 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Scotland
Elsevier Ltd
01.06.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!